BIIB Financials
Biogen Inc - Financial statements & key metrics
Stock Price
$191.82
Market Cap
$28.15B
P/E Ratio
21.8
EPS
$8.79
Income Statement Highlights
Most Recent Quarter: FY
Revenue
$9.89B
Gross Profit
$7.49B
Operating Income
-
Net Income
$1.29B
EPS (Diluted)
$8.79
Balance Sheet Highlights
Total Assets
$29.44B
Total Liabilities
$11.18B
Shareholders Equity
$18.26B
Cash & Equivalents
-
Total Debt
-
Cash Flow Highlights
Operating Cash Flow
$2.20B
CapEx
$153.80M
Free Cash Flow
$2.36B
Profitability Metrics
Gross Margin
78.9%
Operating Margin
0.2%
Net Margin
0.1%
ROE
0.1%
View Complete Financial Statements
Full income statements, balance sheets, and cash flows for multiple periods
Open Full FinancialsFrequently Asked Questions
What is BIIB revenue?
BIIB's most recent quarterly revenue was $9.89B. Annual revenue can be calculated by summing the four most recent quarters.
Is BIIB profitable?
BIIB reported a profit of $1.29B in the most recent quarter. The net profit margin is 0.1%.
What is BIIB market cap?
BIIB has a market capitalization of $28.15B, making it a large-cap stock.
Does BIIB have debt?
View BIIB's balance sheet for debt information.
What is BIIB cash flow?
BIIB's most recent quarterly free cash flow was $2.36B.